Results 181 to 190 of about 232,754 (343)

Derivation and validation of a new prediction score for bacteremia in the emergency department. [PDF]

Sci Rep
Ohno H, Takahashi J, Kato S, Ishii K, Hiramatsu K.   +4 more
europepmc   +1 more source

Nasal Carriage as a Source of Staphylococcus aureus Bacteremia

, 2001
C. Eiff, K. Becker, K. Machka, H. Stammer, G. Peters   +4 more
semanticscholar   +1 more source

Bacterial proliferation is comparable in red blood cell concentrates stored in DEHT/PAGGSM and DEHP/SAGM containers

Vox Sanguinis, EarlyView.
Abstract Background and Objectives The European Union's ban on the use of di(2‐ethylhexyl) phthalate (DEHP) in medical devices will take effect in 2030. DEHP is a plasticizer in polyvinyl chloride blood bags that helps stabilize the red blood cell membrane during hypothermic red blood cell concentrate (RBCC) storage.
Sandra Ramirez‐Arcos, Yuntong Kou, Dilini Kumaran, Geraldine M. Walsh, Anita Howell, Chryslain Sumian, Stefan Reichenberg, Quentin Brebant, Ken McTaggart   +8 more
wiley   +1 more source

Pathogen‐reduced platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections, 2017–2024

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Pathogen reduction (PR) using amotosalen‐UVA was implemented for 100% of platelet concentrates (PCs) in France in November 2017. No bacterial testing was in place earlier. The impact of PR on the risk of transfusion‐transmitted infections (TTIs) from November 2017 to December 2022 (vs.
Syria Laperche, Virginie de la Taille, Pierre Gallian, Elodie Pouchol, Catherine Humbrecht, Alexandre Montembault, Lucile Malard, Caroline Bacquet, Marianne Asso‐Bonnet, Sophie Le Cam, Thierry Peyrard, Pierre Tiberghien   +11 more
wiley   +1 more source

Epidemiology of pediatric invasive group A streptococcus infection in a Saudi tertiary care center. [PDF]

Ann Saudi Med
Ali A, Alhuthil R, Gashgarey D, Altayeb M, Alsuhaibani M, Al-Shareef D, Al-Ansari R, Dahhan A, Adeeb S, Aljumaa R, AlGhalayini B, Alghamdi S, Aljumaah S, Alyabes O, Albanyan EA, Al-Hajjar S.   +15 more
europepmc   +1 more source

Parenteral iron—Does it increase infection risk?

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Iron deficiency (ID) and iron deficiency anaemia (IDA) are prevalent conditions impacting various patient populations, both surgical and non‐surgical conditions. The advent of patient blood management (PBM) has promoted intravenous (IV) iron therapy as an alternative to oral iron and blood transfusions.
Joyisa Deb, Aswin K. Mohan, Suhasini Sil, Suvro Sankha Datta, Yoghini Nagandran, Manideepa Maji, Mohammad Kamrul Hassan Majumder, Saikat Mandal   +7 more
wiley   +1 more source

Daptomycin failure in the treatment of Enterococcus faecium bacteremia: microbiological insights and the importance of dual therapy including beta-lactam. [PDF]

Crit Care
Luque Paz D, Tattevin P.
europepmc   +1 more source

Endoscopic Thrombin Injection for Gastric Variceal Bleeding: A Systematic Review and Meta‐Analysis of Observational and Trial Data

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objective The safety of endoscopic thrombin injection (ETI) for treating the bleeding of gastric varix (GV) in patients with portal hypertension requires further evaluation. This meta‐analysis systematically reviews the available evidence on the efficacy and safety of ETI for GV bleeding.
Wen Xu, Da‐qin Zhan, Ruo‐lan Wang, Shu Jin, Hui‐guo Ding   +4 more
wiley   +1 more source

Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy.

Journal of the Pediatric Infectious Diseases Society, 2018
C. Duplessis, B. Biswas, B. Hanisch, B. Hanisch, M. Perkins, M. Henry, Javier Quiñones, D. Wolfe, Luis A. Estrella, Theron Hamilton   +9 more
semanticscholar   +1 more source

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender, Lauren Pommert, Lori R. Backus, Andrea Bidwell, Courtney Blank, Erin H. Breese, Karen C. Burns, Adam Lane, Lynn H. Lee, Benjamin Mizukawa, Robin E. Norris, Maureen M. O'Brien, Daniel Peck, Christine Phillips, Thomas D. Ryan, Jennifer Young, Michael Absalon, John P. Perentesis   +17 more
wiley   +1 more source